Enterprises Are Testing Public Cloud GenAI
When it comes to generative AI (GenAI), talk is cheap. If you believe the stream of blogs and PR announcements, every leading cloud provider is busily serving up models and toolkits to eager enterprises, which in turn appear to be diving into exciting, revenue-generating applications in which text, images, video, and sounds are automatically created from natural language input.
Not surprisingly, reality doesn’t match the hype. Instead, the leading cloud providers are mainly selling GenAI products and services to companies looking to build products of their own to address specific enterprise requirements. As to enterprise customers, they’re often users of existing cloud-based AI products (e.g., for machine learning) that plan to develop GenAI applications. The operative word: plan.
Futuriom’s Cloud Tracker Pro recently scoped out a group of customer testimonials from the leading cloud providers – AWS, Microsoft Azure, and Google Cloud. Let’s take a look at what we found.
GenAI Is in Test Mode
When it comes to enterprise use of GenAI, it’s important to qualify your terms. All of the leading cloud providers classify machine learning as GenAI. So when AWS claims that the U.S. National Institutes of Health’s Allen Institute for Brain Science is using its AI, it means that the project is using AWS SageMaker, a machine learning service, with plans to extend its use of AWS GenAI tools later on.
Access CLOUD TRACKER PRO
|
|
Related Articles
How Oracle's Crashing the Hyperscalers' Party
Oracle is now a public cloud leader. Here's how it plans to expand its fiefdom via AI, sovereign and private cloud services, multicloud sharing with Azure, and more.
Microsoft Results Reflect AI Growth and ChallengesMicrosoft reported strong quarterly results this week, but investors want to see even more progress with AI in cloud and other products
Lambda Scores $320 Million for AI Infrastructure CloudLambda, a cloud firm offering access to AI infrastructure via NVIDIA GPUs, has scored $320 million in Series C funding on a valuation of $1.5 billion